title: Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
abstract: Subjects in an disease-endemic area in Orissa, India concomitantly infected with filariasis and intestinal helminths had significantly lower intensity of filarial infection in comparison with those who were infected only with filariasis. Administration of albendazole resulted in a significant decrease in the prevalence of filarial antigenemia in subjects concomitantly infected with intestinal helminths, but produced little change in this infection measure in subjects infected only with Wuchereria bancrofti. These results indicate that intestinal helminths could play a role in the anti-filarial activity of albendazole, most probably by depressing filarial infection intensity in co-infected individuals. Confirmation of these findings in a larger cohort may yield important new insights regarding the role of using albendazole in the ongoing intervention programs for the control of lymphatic filariasis.
authors.affiliation: Division of Immunology, Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar, India.
authors.forename: Prakash K
authors.initials: PK
authors.lastname: Sahoo
authors.forename: Ashok K
authors.initials: AK
authors.lastname: Satapathy
authors.forename: Edwin
authors.initials: E
authors.lastname: Michael
authors.forename: Balachandran
authors.initials: B
authors.lastname: Ravindran
mesh_terms: D000293:Adolescent; D000328:Adult; D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001196:Ascariasis / Q000150:complications / Q000188:drug therapy / Q000469:parasitology; D001200:Ascaris / Q000187:drug effects; D004605:Elephantiasis, Filarial / Q000150:complications* / Q000188:drug therapy / Q000469:parasitology; D005260:Female; D005369:Filaricides / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000150:complications* / Q000188:drug therapy / Q000469:parasitology; D008297:Male; D008875:Middle Aged; D018512:Parasitemia / Q000188:drug therapy / Q000469:parasitology; D013321:Strongyloides / Q000187:drug effects; D013322:Strongyloidiasis / Q000150:complications / Q000188:drug therapy / Q000469:parasitology; D016896:Treatment Outcome; D014958:Wuchereria bancrofti / Q000187:drug effects
chemical_list: D005369:Filaricides; D015766:Albendazole